Literature DB >> 10701853

Prenatal diagnosis of RAG-deficient Omenn syndrome.

A Villa1, F Bozzi, C Sobacchi, D Strina, A Fasth, S Pasic, L D Notarangelo, P Vezzoni.   

Abstract

Mutations in recombination activating genes (RAG) 1 and 2 have been found to cause Omenn syndrome (OS), a severe combined immunodeficiency (SCID) with a peculiar phenotype. Here we report the prenatal diagnosis performed in three OS patients. Mutations were detected in the probands as well as in their parents by genomic sequencing of the complete coding regions of both RAG 1 and RAG 2, which are contained in a single exon. All the three probands had RAG 1 mutations in both alleles, at least one of which was a missense substitution. Of the three fetuses tested, one had a wild type sequence on both alleles, while the other two had one mutated allele. None of the three patients were predicted to be affected and this was confirmed at birth. Detection of RAG genes mutations on fetal samples by direct sequencing is an easy and effective way to investigate fetuses from families affected with RAG-dependent SCID and OS families affected by RAG-dependent SCID and OS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701853

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience.

Authors:  Srdjan Pasic; Dragana Vujic; Dobrila Veljković; Bojana Slavkovic; Marija Mostarica-Stojkovic; Predrag Minic; Aleksandra Minic; Goran Ristic; Silvia Giliani; Anna Villa; Cristina Sobacchi; Desa Lilić; Mario Abinun
Journal:  J Clin Immunol       Date:  2014-02-01       Impact factor: 8.317

2.  Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders.

Authors:  David Buchbinder; Rebecca Baker; Yu Nee Lee; Juan Ravell; Yu Zhang; Joshua McElwee; Diane Nugent; Emily M Coonrod; Jacob D Durtschi; Nancy H Augustine; Karl V Voelkerding; Krisztian Csomos; Lindsey Rosen; Sarah Browne; Jolan E Walter; Luigi D Notarangelo; Harry R Hill; Attila Kumánovics
Journal:  J Clin Immunol       Date:  2014-12-17       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.